Follow-up of patients treated with oral doxycycline for Lyme neuroborreliosis

Scandinavian Journal of Infectious Diseases
K KarkkonenM Karlsson

Abstract

The clinical outcome for 69 patients treated with oral doxycycline for Lyme neuroborreliosis was studied retrospectively. The clinical follow-up time was 14 d to 2 y (median 7 months). All patients improved during and after treatment. A complete recovery was seen in 56 patients by 14 d to 9 months (median 6 weeks) after therapy, while 13 patients (19%) still had persistent sequelae 1 y after antibiotic treatment. Six patients were retreated because of new or persistent symptoms, but in no patient was a treatment failure proven. A questionnaire was sent to each patient, asking for time to recovery, sequelae and relapse of symptoms. No patient had experienced relapse of symptoms associated with Lyme neuroborreliosis when answering the questionnaire 2-9 y after treatment. Oral doxycycline seems to be an effective, convenient and inexpensive alternative for the treatment of Lyme neuroborreliosis.

References

Aug 15, 1992·Annals of Internal Medicine·R B NadelmanG P Wormser
Feb 1, 1991·The Journal of Infectious Diseases·H W PfisterK M Einhäupl
Dec 1, 1989·Journal of the American Academy of Dermatology·B W Berger, R C Johnson
Aug 31, 1989·The New England Journal of Medicine·A C Steere
Jan 1, 1988·Annals of the New York Academy of Sciences·R AckermannR Schmidt
Aug 1, 1987·European Journal of Clinical Microbiology·V P MursicE Süss
Nov 16, 1995·The New England Journal of Medicine·J BerglundR Norrby
Jul 1, 1993·Clinics in Dermatology·G Stiernstedt
Jul 1, 1993·Antimicrobial Agents and Chemotherapy·J M LevinF Strle
Jul 31, 1997·The New England Journal of Medicine·R J DattwylerD Maladorno
Apr 8, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L Dotevall, L Hagberg

❮ Previous
Next ❯

Citations

Nov 3, 2005·Current Neurology and Neuroscience Reports·John J Halperin
Nov 26, 2009·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A MyglandUNKNOWN European Federation of Neurological Societies
Jul 29, 2015·Nature Reviews. Neurology·Uwe KoedelHans-Walter Pfister
Sep 13, 2002·Acta Neurologica Scandinavica·M VrethemP Forsberg
Aug 4, 2011·Expert Review of Anti-infective Therapy·Paul M Lantos
Jun 14, 2003·Vector Borne and Zoonotic Diseases·John J Halperin
Dec 1, 2005·Journal of Chemotherapy·R S Taylor, I N Simpson
Jul 22, 2004·Current Infectious Disease Reports·John J. Halperin
Sep 25, 2003·Muscle & Nerve·John J Halperin
Dec 8, 2005·CNS Drugs·Göran Günther, Mats Haglund
Aug 6, 2002·Scandinavian Journal of Infectious Diseases·Johan BerglundHallstein Walter
Jan 29, 2005·Current Treatment Options in Neurology·Andrew R Pachner
Feb 15, 2007·Current Treatment Options in Neurology·John J Halperin
Jun 19, 2009·Der Nervenarzt·R Kaiser, V Fingerle
Oct 10, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gary P WormserRobert B Nadelman
May 18, 2012·The Pediatric Infectious Disease Journal·Amy D ThompsonLise E Nigrovic
Apr 18, 2020·Ticks and Tick-borne Diseases·Aris GarroUNKNOWN for Pedi Lyme Net

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.